🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

30,00 USD

Máx. histórico

61,25

1783 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-51,02%

Rango 52 semanas

23,62 – 31,05

Variación hoy

-2,19%

Cierre anterior

30,67

Rango de hoy

29,89 – 31,05

Volumen hoy

52.747.281

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,32%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
39,47 (puede no estar actualizado)
Dividend yield
5,61% (puede no estar actualizado)
Precio objetivo analistas
29,26 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 14 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 5,73%
Fecha de pago Importe por participación
24/07/2026 0,4300 USD
08/05/2026 0,4300 USD
23/01/2026 0,4300 USD
07/11/2025 0,4300 USD
25/07/2025 0,4300 USD
09/05/2025 0,4300 USD
24/01/2025 0,4300 USD
08/11/2024 0,4200 USD
26/07/2024 0,4200 USD
09/05/2024 0,4200 USD
25/01/2024 0,4200 USD
09/11/2023 0,4100 USD
27/07/2023 0,4100 USD
11/05/2023 0,4100 USD
26/01/2023 0,4100 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
10/10/2022 42,35 42,62 41,75 41,75 -1,35% 2,05% 17.888.000
07/10/2022 43,05 43,05 41,92 42,32 -1,79% 2,62% 20.095.000
06/10/2022 43,76 43,78 43,04 43,09 -2,33% 1,69% 22.068.200
05/10/2022 44,12 44,37 43,68 44,12 -0,76% 1,56% 15.673.400
04/10/2022 44,25 44,84 44,09 44,46 +0,72% 1,69% 28.198.800
03/10/2022 44,07 44,28 43,49 44,14 +0,87% 1,79% 22.834.300
30/09/2022 44,17 44,61 43,73 43,76 -0,91% 1,99% 22.962.300
29/09/2022 44,41 44,62 43,95 44,16 -0,61% 1,51% 13.559.900
28/09/2022 44,67 44,81 44,22 44,43 +0,77% 1,32% 16.532.600
27/09/2022 44,22 44,58 43,74 44,09 +0,59% 1,90% 21.562.700
26/09/2022 43,81 44,33 43,67 43,83 -0,57% 1,51% 18.680.200
23/09/2022 44,44 44,56 43,58 44,08 -1,10% 2,21% 18.871.700
22/09/2022 43,67 45,00 43,52 44,57 +1,48% 3,39% 18.508.100
21/09/2022 44,81 44,98 43,90 43,92 -1,90% 2,41% 17.505.200
20/09/2022 45,00 45,27 44,44 44,77 -1,47% 1,84% 15.369.000
19/09/2022 45,68 45,88 44,78 45,44 -1,28% 2,41% 16.256.200
16/09/2022 46,09 46,62 45,64 46,03 +0,20% 2,13% 30.629.500
15/09/2022 46,11 46,29 45,70 45,94 -0,46% 1,28% 15.802.000
14/09/2022 46,20 46,41 45,78 46,15 -0,09% 1,36% 17.162.500
13/09/2022 47,13 47,32 46,02 46,19 -3,29% 2,76% 16.603.200
12/09/2022 48,08 48,35 47,69 47,76 -0,17% 1,37% 13.744.800
09/09/2022 47,20 47,99 47,10 47,84 +1,61% 1,89% 17.501.700
08/09/2022 46,02 47,12 45,87 47,08 +2,06% 2,72% 18.271.000
07/09/2022 45,70 46,21 45,38 46,13 +0,81% 1,82% 15.378.900
06/09/2022 45,96 46,44 45,53 45,76 +0,13% 1,98% 17.153.500
02/09/2022 46,74 46,80 45,53 45,70 -1,99% 2,72% 14.667.700
01/09/2022 45,14 46,65 45,14 46,63 +3,10% 3,35% 19.947.600
31/08/2022 46,01 46,29 45,13 45,23 -1,35% 2,52% 26.416.800
30/08/2022 46,34 46,35 45,80 45,85 -0,82% 1,19% 16.303.000
29/08/2022 46,38 46,69 46,12 46,23 -1,26% 1,23% 13.400.500